Researchers from Second Affiliated Hospital of Nanjing Medical University Detail Research in Carcinomas (Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma)

Prensa/medios de comunicación: Research

Períodosep. 5 2023

Cobertura de los medios

1

Cobertura de los medios

  • NombreResearchers from Second Affiliated Hospital of Nanjing Medical University Detail Research in Carcinomas (Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma)
    Nombre/canal del medio de comunicaciónImmunotherapy Daily
    País/TerritorioUnited States
    Fecha9/5/23
    PersonasJun Wang